Evidence map›Paper›PMID 39862400›Full record

ArticleRheumatology (Oxford, England)2025

Predictive value of insulin resistance metabolic score for cardiovascular disease in Chinese arthritis patients: a prospective cohort study.

Wen-Kai Ke, Ling-Ling Xu, Ni Luo

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wen-Kai KeDepartment of Gerontology, CR & WISCO General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Ling-Ling XuDepartment of Gerontology, CR & WISCO General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei, China.ORCID 0009-0005-1047-0246
Ni LuoDepartment of Gerontology, CR & WISCO General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei, China.ORCID 0009-0007-7635-2247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAlthough patients with arthritis have significantly increased cardiovascular disease (CVD) risk, effective prediction tools remain limited. This study aimed to evaluate the predictive value of the Metabolic Score for Insulin Resistance (METS-IR) for CVD events among Chinese patients with arthritis.

methodsUsing data from the China Health and Retirement Longitudinal Study (CHARLS), we conducted a 7-year prospective cohort study (2011-2018) involving 1059 patients with arthritis. The primary exposure was baseline METS-IR, and the primary outcome was incident CVD. Multivariate Cox regression models were used to analyse the association between METS-IR and CVD risk, adjusting for demographic characteristics and lifestyle factors.

resultsAfter adjusting for confounding factors, each quartile increase in METS-IR was associated with a 36% increased risk of CVD (hazard ratio [HR] = 1.36, 95% CI: 1.14-1.61, P < 0.001). Compared with the lowest quartile, the highest quartile showed a 63% increased risk (HR = 1.63, 95% CI: 1.12-2.37, P < 0.05), demonstrating a significant dose-response relationship (P for trend < 0.05).

conclusionMETS-IR serves as an effective tool for predicting CVD risk among Chinese patients with arthritis, providing new strategies for early risk identification and prevention.

Indexed as

ArthritisCardiovascular DiseasesInsulin ResistanceMetabolic SyndromeAgedChinaEast Asian PeopleFemaleHumansLongitudinal StudiesMaleMiddle AgedPredictive Value of TestsProspective StudiesRisk AssessmentRisk Factorsarthritiscardiovascular diseasedose–response relationshipMETS-IRprospective cohort study

Identifiers

PMID39862400
PMCPMC12107042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.